Skip to contents

  1. Schirizzi, Annalisa; Contino, Marialessandra; Carrieri, Livianna; Riganti, Chiara; De Leonardis, Giampiero; Scavo, Maria Principia; Perrone, Maria Grazia; Miciaccia, Morena; Kopecka, Joanna; Refolo, Maria Grazia; Lotesoriere, Claudio; Depalo, Nicoletta; Rizzi, Federica; Giannelli, Gianluigi; Messa, Caterina; D’Alessandro, Rosalba

    The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Frontiers Media SA, 2023

    Published in: Frontiers in Oncology

  2. Vicente, Belén; López-Abán, Julio; Chaccour, Juliane; Hernández-Goenaga, Juan; Nicolas, Patricia; Fernández-Soto, Pedro; Muro, Antonio; Chaccour, Carlos

    The effect of ivermectin alone and in combination with cobicistat or elacridar in experimental Schistosoma mansoni infection in mice

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Springer Science and Business Media LLC, 2021

    Published in: Scientific Reports

  3. Goutal, Sébastien; Langer, Oliver; Auvity, Sylvain; Andrieux, Karine; Coulon, Christine; Caillé, Fabien; Gervais, Philippe; Cisternino, Salvatore; Declèves, Xavier; Tournier, Nicolas

    Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Springer Science and Business Media LLC, 2018

    Published in: Drug Delivery and Translational Research

  4. Chen, Haiyang; Shien, Kazuhiko; Suzawa, Ken; Tsukuda, Kazunori; Tomida, Shuta; Sato, Hiroki; Torigoe, Hidejiro; Watanabe, Mototsugu; Namba, Kei; Yamamoto, Hiromasa; Soh, Junichi; Asano, Hiroaki; Miyoshi, Shinichiro; Toyooka, Shinichi

    Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Spandidos Publications, 2017

    Published in: Oncology Letters